pepdex
← Back to index
№ 041

Dihexa

Angiotensin IV analog with strong synaptogenic effect in animal models. Often-cited as 'BDNF on steroids.' Very limited human data.

Nootropic
Evidence: Anecdotal
Half-life
~hours (poorly characterized in humans)
Route
Oral or transdermal (not injected)
Cycle
2-4 weeks at a time
Schedule
Daily
In plain English

Dihexa is a small peptide derived from angiotensin IV. In animal studies it dramatically increases brain synaptogenesis — sometimes called 'BDNF on steroids'. Human data is very limited. Treat as experimental and watch the malignancy concern (synaptogenic + growth signal).

Status & legality
Natty?
Not natty
FDA
Not approved

Not FDA approved. Pre-clinical research compound.

Compounding
Not classified

Not formally categorized in the FDA bulks lists.

WADA
Not listed
Prescribed

Not prescribed in conventional medicine.

Who it's for

  • →Users prioritizing cognitive function with experimental tolerance
  • →Brain-injury recovery contexts
  • →Stack with caution and short cycles

What to expect

  1. Week 1

    Subjective cognitive shifts within days for responders.

  2. Week 4

    Cycle endpoint — limited safety data on chronic use.

  3. Week 8

    Off-cycle. Reassess.

How it works (mechanism)

Hexapeptide angiotensin IV analog. Activates the HGF/c-Met signaling pathway with reported synaptogenic effects in animal models. Limited human data on safety or efficacy.

Dosing protocol

8-30 mg orally or transdermally daily. No standardized human protocol.

Stacks well with

Standalone — too experimental to compound effects

Side effects

01Limited human safety data
02Anecdotal: headache, irritability
03Theoretical: tumor-growth concern (synaptogenic + general growth signal)

When NOT to use

  • ⚠Active malignancy (theoretical concern)
  • ⚠Pregnancy / nursing
  • ⚠Anyone risk-averse to early-data peptides

Common mistakes

  • • Long cycles without safety data
  • • Stacking with multiple experimental nootropics
  • • Dismissing the theoretical malignancy concern

Educational only. User-specific dosing is between you and a qualified provider.

Frequently asked

What is Dihexa?+
Dihexa is a small peptide derived from angiotensin IV. In animal studies it dramatically increases brain synaptogenesis — sometimes called 'BDNF on steroids'. Human data is very limited. Treat as experimental and watch the malignancy concern (synaptogenic + growth signal).
Is Dihexa FDA approved?+
Not FDA approved. Pre-clinical research compound.
Is Dihexa banned by WADA?+
Dihexa is not currently on the WADA prohibited list.
Are you still natty after taking Dihexa?+
No. Dihexa is a performance-enhancing peptide and would disqualify a strict natty claim.
Do doctors prescribe Dihexa?+
Not prescribed in conventional medicine.
What's the typical dose of Dihexa?+
8-30 mg orally or transdermally daily. No standardized human protocol.
What are the side effects of Dihexa?+
Common side effects include: Limited human safety data; Anecdotal: headache, irritability; Theoretical: tumor-growth concern (synaptogenic + general growth signal). Less common effects and full safety details are on the entry page.
How long until Dihexa starts working?+
Subjective cognitive shifts within days for responders.

More in Nootropic

№ 033
Oxytocin

The 'bonding hormone' you make naturally. Synthetic oxytocin is FDA-approved for labor; off-label use covers social, anxiety, and intimacy contexts.

№ 047
Cerebrolysin

Porcine brain-derived peptide complex. Used clinically in 50+ countries (Russia, China, Mexico, EU) for stroke recovery, TBI, and Alzheimer's. Mixture of low-molecular-weight peptides, not a single compound.

№ 030
Semax

Russian-origin nootropic peptide. Alert/focus end of the spectrum. Pairs with Selank for a balanced cognitive stack.

№ 026
DSIP

Delta Sleep-Inducing Peptide. A brain-origin peptide aimed at sleep architecture. Limited human data, mixed user reports.